Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Revenues $ 17,840,000 $ 6,271,000
Cost of sales 13,892,000 4,933,000
Gross profit 3,948,000 1,338,000
Operating expenses:    
Selling and administrative 4,536,000 3,498,000
Research and development 1,223,000 1,967,000
Total operating expenses 5,759,000 5,465,000
Operating loss (1,811,000) (4,127,000)
Interest expense (328,000) (3,000)
Net loss $ (2,139,000) $ (4,130,000)
Net loss per share - basic and diluted $ (0.13) $ (0.30)
Weighted average number of common shares outstanding - basic and diluted 15,997,296 13,804,475